← All trials
NCT01727401
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2012
- Primary completion
- Aug 1, 2017
- Completion date
- Sep 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 117
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- D'Annunzio University of Chieti–PescaraLead sponsor
- D'Annunzio University of Chieti–PescaraStudy chair
- D'Annunzio University of Chieti–PescaraReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.